Ph.D., CEO, OneThree Biotech
Neel S. Madhukar is the CEO and co-founder of OneThree Biotech, a biotechnology startup developing artificial intelligence platforms to accelerate drug development by efficiently predicting drug targets and clinical effects. He received his PhD in Computational Biology and Medicine at Weill Cornell Medical College in the lab of Dr. Olivier Elemento and has authored numerous scientific publications in the fields of machine learning, pharmacology, and precision medicine. In one of his recent publications, Neel and his team used machine learning to identify dopamine receptors as the binding target of a novel anti-cancer agent, opening up a new avenue for targeting cancer. For this work, Neel was awarded a PhRMA foundation informatics fellowship for PhD and was named one of Forbes’ “30 under 30 in Healthcare” in 2016. He is currently based at Cornell Tech’s Runway Startup Incubator where he continues his research on AI in drug development and works to further develop OneThree Biotech.
Presentation Title and Company Description
AI and Data Science Showcase: Using AI to Accelerate Early-stage Drug Development
OneThree Biotech is a New York based startup that uses AI to accelerate drug development. Our proprietary platform integrates multiple data types to predict binding targets, biomarkers, and clinical effects. This allows researchers to focus their experiments and develop better medicines, faster.